awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33925672-80B49832-32E3-47B7-9E22-D8DB30FFEC79
Q33925672-80B49832-32E3-47B7-9E22-D8DB30FFEC79
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33925672-80B49832-32E3-47B7-9E22-D8DB30FFEC79
Molecular therapy for acute myeloid leukaemia.
P2860
Q33925672-80B49832-32E3-47B7-9E22-D8DB30FFEC79
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33925672-80B49832-32E3-47B7-9E22-D8DB30FFEC79
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
87280cef3c6ea4d0c2e8a47037bd12f24f95eaed
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.